Russian Clinical Laboratory Diagnostics · 2019 · 13 citations · 4 references
Life SciencesImmunologyInternal MedicineAutoimmunityInflammationRheumatologyAutoimmune DiseasesAutoimmune Rheumatic DiseasesChronic InflammationInflammatory ArthritisInflammatory BiomarkersRheumatoid ArthritisBetween-group ComparisonC-reactive Protein TestingComparison Group DesignGroup Comparison AnalysisSubjectsSystemic Inflammation Markers
The purpose of this study was to determine the level of nesfatin-1 (NF-1) in the blood serum of healthy volunteers and patients with rheumatoid arthritis (RA) to establish the threshold for normal values of this parameter and to reveal the relationship between the level of NF-1 and clinical manifestations of RA. We examined 170 people, of which 110 patients with RA and 60 donors who made up the comparison group. The mean level of serum nesfatin-1 in healthy subjects was 31.61 ± 3.17 ng/ml (M ± σ). The level of normal values of nesfatin-1 in healthy individuals, defined as M ± 2σ, was from 25.27 to 37.95 ng/ml. These studies showed the relationship between the concentration of NF-1 and the severity of clinical manifestations of RA. We found that a higher serum level of NF-1 was characteristic of patients with a more severe clinical course of the disease. The data obtained indicate that high level of NF-1 positively correlates with higher concentrations of C-reactive protein and ESR. This data indirectly proves the proinflammatory effect of NF-1 and confirms the hypothesis about the primary role of systemic inflammation in the pathogenesis of RA.
4
Identification of nesfatin-1 as a satiety molecule in the hypothalamus
Shinsuke Oh‐I, Hiroyuki Shimizu, Tetsurou Satoh et al. · Nature · 2006 · 998 citations
Nesfatin-1 and its effects on different systems.
Ceylan Ayada, Ümran Toru, Yasemin Korkut · PubMed · 2015 · 104 citations